{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:39:49Z","timestamp":1771562389699,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[1999,2,1]]},"DOI":"10.1038\/sj.gt.3300798","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T16:50:39Z","timestamp":1032367839000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine"],"prefix":"10.1038","volume":"6","author":[{"given":"H","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K M","family":"Giezeman-Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Attanucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W K","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M T","family":"Lotze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W H","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E","family":"Bozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,2,5]]},"reference":[{"key":"BF3300798_CR1","first-page":"183","volume":"21","author":"JB Murphy","year":"1926","unstructured":"Murphy JB, Sturm E . Conditions determining the transplantability of tissues in the brain Rockefeller Inst Med Res 1926 21: 183\u2013197","journal-title":"Rockefeller Inst Med Res"},{"key":"BF3300798_CR2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.4049\/jimmunol.159.5.2399","volume":"159","author":"LB Gordon","year":"1997","unstructured":"Gordon LB et al. Growth of P511 mastocytoma cells in BALB\/c mouse brain elicits CTL response without tumor elimination J Immunol 1997 159: 2399\u20132408","journal-title":"J Immunol"},{"key":"BF3300798_CR3","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1200\/JCO.1989.7.11.1701","volume":"7","author":"MS Mitchell","year":"1989","unstructured":"Mitchell MS . Relapse in the central nervous system in melanoma patients successfully treated with biomodulators J Clin Oncol 1989 7: 1701\u20131709","journal-title":"J Clin Oncol"},{"key":"BF3300798_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0165-5728(89)90127-6","volume":"25","author":"C DeMicco","year":"1989","unstructured":"DeMicco C . Immunology of central nervous system tumors (review) J Neuroimmunol 1989 25: 93\u2013108","journal-title":"J Neuroimmunol"},{"key":"BF3300798_CR5","first-page":"182","volume":"6","author":"B Kalman","year":"1993","unstructured":"Kalman B, Lublin FD . Immunopathogenic mechanisms in experimental allergic encephalomyelitis (review) Curr Opin Neurol Neurosurg 1993 6: 182\u2013188","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"BF3300798_CR6","doi-asserted-by":"publisher","first-page":"10399","DOI":"10.1073\/pnas.93.19.10399","volume":"93","author":"JH Sampson","year":"1996","unstructured":"Sampson JH et al. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the \u2018immunologically privileged\u2019 central nervous system Proc Natl Acad Sci USA 1996 93: 10399\u201310404","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300798_CR7","first-page":"1828","volume":"56","author":"H Wakimoto","year":"1996","unstructured":"Wakimoto H et al. Intensified antitumor immunity by a cancer vaccine that produces granulocyte\u2013macrophage colony-stimulating factor plus interleukin 4 Cancer Res 1996 56: 1828\u20131833","journal-title":"Cancer Res"},{"key":"BF3300798_CR8","doi-asserted-by":"crossref","unstructured":"Bozik ME, Chambers WH, Gilbert M, Lotze MT . Treatment of 9L gliosarcoma with IL-4 producing 9L vaccine. FASEB meeting 1996 (Abstr )","DOI":"10.1097\/00002371-199611000-00044"},{"key":"BF3300798_CR9","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1073\/pnas.81.19.6149","volume":"81","author":"R Noelle","year":"1984","unstructured":"Noelle R et al. Increased expression of Ia antigens on resting B cells Proc Natl Acad Sci USA 1984 81: 6149\u20136153","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300798_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1084\/jem.165.1.157","volume":"165","author":"J Hu-Li","year":"1987","unstructured":"Hu-Li J et al. B cell stimulatory factor I (interleukin 4) is a potent costimulant for normal resting T lymphocytes J Exp Med 1987 165: 157\u2013161","journal-title":"J Exp Med"},{"key":"BF3300798_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1084\/jem.168.6.2183","volume":"168","author":"Y Kawakami","year":"1988","unstructured":"Kawakami Y, Rosenberg SA, Lotze MT . Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma J Exp Med 1988 168: 2183\u20132191","journal-title":"J Exp Med"},{"key":"BF3300798_CR12","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.4049\/jimmunol.159.9.4532","volume":"159","author":"JL Barks","year":"1997","unstructured":"Barks JL, McQuillan JJ, Iademarco MF . TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells J Immunol 1997 159: 4532\u20134538","journal-title":"J Immunol"},{"key":"BF3300798_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0092-8674(89)90925-2","volume":"57","author":"RI Tepper","year":"1989","unstructured":"Tepper RI, Pattengale PK, Leder P . Murine interleukin-4 displays potent anti-tumor activity in vivo Cell 1989 57: 503\u2013512","journal-title":"Cell"},{"key":"BF3300798_CR14","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.153.12.5659","volume":"153","author":"F Pericle","year":"1994","unstructured":"Pericle F et al. An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 J Immunol 1994 153: 5659\u20135673","journal-title":"J Immunol"},{"key":"BF3300798_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1126\/science.1948050","volume":"254","author":"PT Golumbek","year":"1991","unstructured":"Golumbek PT et al. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4 Science 1991 254: 713\u2013716","journal-title":"Science"},{"key":"BF3300798_CR16","unstructured":"Bozik ME et al. T-cell dependent intracerebral tumor regression of a 9L gliosarcoma expressing mIL-4 in a syngeneic host. Proc Annu Meet Am Assoc Cancer Res 1996; 36: A2800 (Abstr )"},{"key":"BF3300798_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/nm1295-1297","volume":"1","author":"JI Mayordomo","year":"1995","unstructured":"Mayordomo JI et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity Nature Med 1995 1: 1297\u20131302","journal-title":"Nature Med"},{"key":"BF3300798_CR18","first-page":"63","volume":"26","author":"M Rosenzwajg","year":"1998","unstructured":"Rosenzwajg M, Camus S, Guigon M, Gluckman JC . The influence of interleukin (IL)-4, IL-13, and Flt3 ligand on human dendritic cell differentiation from cord blood CD34+ progenitor cells Exp Hematol 1998 26: 63\u201372","journal-title":"Exp Hematol"},{"key":"BF3300798_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1126\/science.1317968","volume":"256","author":"KW Culver","year":"1992","unstructured":"Culver KW et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 1992 256: 1550\u20131552","journal-title":"Science"},{"key":"BF3300798_CR20","first-page":"83","volume":"53","author":"Z Ram","year":"1993","unstructured":"Ram Z et al. In situ retroviral gene transfer for the treatment of brain tumors in rats Cancer Res 1993 53: 83\u201388","journal-title":"Cancer Res"},{"key":"BF3300798_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/nm1297-1354","volume":"3","author":"Z Ram","year":"1997","unstructured":"Ram Z et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producer cells Nature Med 1997 3: 1354\u20131361","journal-title":"Nature Med"},{"key":"BF3300798_CR22","first-page":"5276","volume":"46","author":"FL Moolten","year":"1986","unstructured":"Moolten FL . Tumor chemosensitivity conferred by inserted Herpes thymidine kinase genes: paradigm for a prospective cancer control strategy Cancer Res 1986 46: 5276\u20135281","journal-title":"Cancer Res"},{"key":"BF3300798_CR23","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1073\/pnas.91.10.4348","volume":"91","author":"D Barba","year":"1994","unstructured":"Barba D, Hardin J, Sadelain M, Gage FH . Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors Proc Natl Acad Sci USA 1994 91: 4348\u20134352","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300798_CR24","first-page":"3758","volume":"56","author":"SH Chen","year":"1996","unstructured":"Chen SH et al. Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival Cancer Res 1996 56: 3758\u20133762","journal-title":"Cancer Res"},{"key":"BF3300798_CR25","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1089\/hum.1997.8.11-1345","volume":"8","author":"S Benedetti","year":"1997","unstructured":"Benedetti S et al. Limited efficacy of the HSV-TK\/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene Hum Gene Ther 1997 8: 1345\u20131353","journal-title":"Hum Gene Ther"},{"key":"BF3300798_CR26","first-page":"6477","volume":"54","author":"SE Townsend","year":"1994","unstructured":"Townsend SE, Su FW, Atherton JM, Allison JP . Specificity and longevity of antitumor immune responses induced by B7-transfected tumors Cancer Res 1994 54: 6477\u20136483","journal-title":"Cancer Res"},{"key":"BF3300798_CR27","first-page":"6022","volume":"54","author":"A Allione","year":"1994","unstructured":"Allione A et al. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte\u2013macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants Cancer Res 1994 54: 6022\u20136026","journal-title":"Cancer Res"},{"key":"BF3300798_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hum.1996.7.1-1","volume":"7","author":"L Santodonato","year":"1996","unstructured":"Santodonato L et al. Cure of mice with established metastatic Friend leukemia cell tumors by a combined therapy with tumor cells expressing both interferon-alpha 1 and herpes simplex thymidine kinase followed by ganciclovir Hum Gene Ther 1996 7: 1\u201310","journal-title":"Hum Gene Ther"},{"key":"BF3300798_CR29","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.4049\/jimmunol.154.12.6466","volume":"154","author":"H Tahara","year":"1995","unstructured":"Tahara H et al. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector J Immunol 1995 154: 6466\u20136474","journal-title":"J Immunol"},{"key":"BF3300798_CR30","first-page":"957","volume":"3","author":"H Okada","year":"1996","unstructured":"Okada H et al. Gene therapy against an experimental glioma using adeno-associated virus vectors Gene Therapy 1996 3: 957\u2013964","journal-title":"Gene Therapy"},{"key":"BF3300798_CR31","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/eji.1830270936","volume":"27","author":"A Stoppacciaro","year":"1997","unstructured":"Stoppacciaro A et al. Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines Eur J Immunol 1997 27: 2375\u20132382","journal-title":"Eur J Immunol"},{"key":"BF3300798_CR32","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff G et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte\u2013macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 1993 90: 3539\u20133543","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300798_CR33","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1073\/pnas.85.17.6460","volume":"85","author":"O Danos","year":"1988","unstructured":"Danos O, Mulligan RC . Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges Proc Natl Acad Sci USA 1988 85: 6460\u20136464","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3300798_CR34","doi-asserted-by":"publisher","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","volume":"90","author":"WS Pear","year":"1993","unstructured":"Pear WS, Nolan GP, Scott ML, Baltimore D . Production of high-titer helper-free retroviruses by transient transfection Proc Natl Acad Sci USA 1993 90: 8392\u20138396","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3300798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3300798","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3300798.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T17:09:36Z","timestamp":1682356176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3300798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2,1]]}},"alternative-id":["BF3300798"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3300798","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2,1]]},"assertion":[{"value":"7 May 1998","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 1998","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 1999","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}